Bo-Sheng Li (Bosheng Li)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Metabolic Syndrome

Neoadjuvant Chemotherapy

Top Venues

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Yun Wu, Yu-Feng Xiao, Li-Xing Tian, Bing He, Jiao Liu, Zhi-Bin Li, Huan Yang, Yang Chen, Qiang Luo, Bo-Sheng Li, Shi-Ming Yang
The hTERT-p50 homodimer inhibits PLEKHA7 expression to promote gastric cancer invasion and metastasis. Oncogene (2023)
Bo-Sheng Li, Houyi Kang, Yufeng Xiao, Yexiang Du, Yunhua Xiao, Guojing Song, Yan Zhang, Yu Guo, Fan Yang, Fengtian He, Shi-Ming Yang
LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1. Oncogene 41 (13) (2022)
Yuyun Wu, Ningbo Hao, Suming Wang, Xin Yang, Yufeng Xiao, Huan Yang, Shi-Ming Yang, Bo-Sheng Li
Long Noncoding RNA Lnc-TLN2-4:1 Suppresses Gastric Cancer Metastasis and Is Associated with Patient Survival. Journal of oncology 2020 (2020)